AXIM Biotechnologies, Inc. (AXIM) stock
AXIMOTCPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2024, quý kết thúc ngày Jun 30, 2024Last filing: 10-Q on Aug 19, 2024
$0.00+0.00 (+2.00%)
Close on Oct 19, 2026Market cap –P/E –Yield –
AXIM Biotechnologies enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
AXIM Biotechnologies's enterprise value was $1.08M on Oct 19, 2026, against $3.13M a year earlier. Over the last 5 years it ranged from $739.92K to $59.87M, with a median of $3.45M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Oct 19, 2026 | $1.08M | -67.5% |
| 2025 | Dec 31, 2025 | $3.33M | +350.2% |
| 2024 | Dec 31, 2024 | $739.92K | -83.9% |
| 2023 | Dec 29, 2023 | $4.58M | +23.8% |
| 2022 | Dec 30, 2022 | $3.70M | -93.8% |
| 2021 | Dec 31, 2021 | $59.87M | +12.8% |
| 2020 | Dec 31, 2020 | $53.05M | +143.9% |
| 2019 | Dec 31, 2019 | $21.75M | -51.0% |
| 2018 | Dec 31, 2018 | $44.39M | -91.2% |
| 2017 | Dec 29, 2017 | $501.64M | +12.2% |
| 2016 | Dec 30, 2016 | $447.12M | +3700.0% |
| 2015 | Dec 31, 2015 | $11.77M | -96.4% |
| 2014 | Dec 31, 2014 | $329.05M | – |
See a number that looks wrong?